
Please try another search
Astria Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is navenibart, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Jill C. Milne | 57 | 2008 | Co-Founder, CEO, President & Director |
Jay D. Horton | - | - | Member of Scientific Advisory Board |
Sekar Kathiresan | 52 | - | Member of Scientific Advisory Board |
Kenneth M. Bate | 75 | 2014 | Independent Chairman of the Board |
Johannes Jacob Pieter Kastelein | 71 | - | Member of Scientific Advisory Board |
Steven E. Shoelson | - | - | Member of Scientific Advisory Board |
Frederick C. Callori | 57 | 2021 | Independent Director |
Edward M. Scolnick | 84 | - | Member of Scientific Advisory Board |
Gregory Anthony Lapointe | 66 | 2019 | Independent Director |
Roger Ulrich | - | - | Member of Scientific Advisory Board |
Michael Jirousek | 66 | 2008 | Member of Scientific Advisory Board |
Eric Brass | - | - | Member of Scientific Advisory Board |
Arthur H. Rubenstein | 88 | - | Member of Scientific Advisory Board |
Michael D. Kishbauch | 76 | 2016 | Independent Director |
Hugh M. Cole | 60 | 2019 | Independent Director |
Jonathan Violin | 50 | 2021 | Independent Director |
Sunil Agarwal | 55 | 2024 | Independent Director |
Joanne T. Beck | 64 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review